Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

2C-T-15

From Wikipedia, the free encyclopedia
This articleneeds additional citations forverification. Please helpimprove this article byadding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "2C-T-15" – news ·newspapers ·books ·scholar ·JSTOR
(November 2007) (Learn how and when to remove this message)
2C-T-15
Names
Preferred IUPAC name
2-[4-(Cyclopropylsulfanyl)-2,5-dimethoxyphenyl]ethan-1-amine
Identifiers
3D model (JSmol)
ChemSpider
UNII
  • InChI=1S/C13H19NO2S/c1-15-11-8-13(17-10-3-4-10)12(16-2)7-9(11)5-6-14/h7-8,10H,3-6,14H2,1-2H3 checkY
    Key: HHAPMOUVSYQKLK-UHFFFAOYSA-N checkY
  • InChI=1/C13H19NO2S/c1-15-11-8-13(17-10-3-4-10)12(16-2)7-9(11)5-6-14/h7-8,10H,3-6,14H2,1-2H3
    Key: HHAPMOUVSYQKLK-UHFFFAOYAY
  • COc2cc(SC1CC1)c(cc2CCN)OC
Properties
C13H19NO2S
Molar mass253.36 g/mol
Melting point203.5 to 204.5 °C (398.3 to 400.1 °F; 476.6 to 477.6 K)
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)
Chemical compound

2C-T-15 or2,5-dimethoxy-4-(β-cyclopropylthio)phenethylamine is apsychedelicphenethylamine of the2C family. It was presumably first synthesized byAlexander Shulgin and reported in his bookPiHKAL (Phenethylamines i Have Known And Loved).

Chemistry

[edit]

2C-T-15 is the2 carbonhomologue ofAleph-15, which has not been synthesized. The full chemical name is 2-[4-(2-cyclopropylthio)-2,5-dimethoxyphenyl]ethanamine. The drug hasstructural properties similar to2C-T-2 and other drugs in the2C-T series.

General information

[edit]

The dosage range of 2C-T-15 is typically 30mg or more. Its duration is unspecified byShulgin, and itsentry in PiHKAL says it lasts for "several hours."[1] The effects are not prominent, and 2C-T-15 is not very potent.

Pharmacology

[edit]

The mechanism that produces 2C-T-15's hallucinogenic and entheogenic effects has not been specifically established; however, it is most likely to result from action as a5-HT2Aserotonin receptoragonist in the brain, a mechanism of action shared by all of the hallucinogenic tryptamines and phenethylamines for which the mechanism of action is known.

Dangers

[edit]

The toxicity of 2C-T-15 is not well documented. 2C-T-15 is much less potent than 2C-T-7, but it may be expected that at very high doses it would display similar toxicity to that of other phenethylamines of the 2C-T family.

Legality

[edit]

2C-T-15 is not explicitly illegal in the USA, but possession and sales of 2C-T-15 could be prosecuted under theFederal Analog Act because of its structural similarities to2C-T-7.

2C-T-15 is a class A drug in the UK under theMisuse of Drugs act.

As of October 31, 2016, 2C-T-15 is a controlled substance (Schedule III) in Canada.[2]

References

[edit]
  1. ^Shulgin, Alexander;Shulgin, Ann (September 1991).PiHKAL: A Chemical Love Story.Berkeley, California: Transform Press.ISBN 0-9630096-0-5.OCLC 25627628.
  2. ^"Canada Gazette – Regulations Amending the Food and Drug Regulations (Part J — 2C-phenethylamines)". 4 May 2016.

External links

[edit]
Psychedelics
(5-HT2A
agonists)
Benzofurans
Lyserg‐
amides
Phenethyl‐
amines
2C-x
25x-NBx
25x-NB
25x-NB3OMe
25x-NB4OMe
25x-NBF
25x-NBMD
25x-NBOH
25x-NBOMe
Atypical structures
25x-NMx
N-(2C)-fentanyl
3C-x
4C-x
DOx
HOT-x
MDxx
Mescaline (subst.)
TMAs
  • TMA
  • TMA-2
  • TMA-3
  • TMA-4
  • TMA-5
  • TMA-6
Others
Piperazines
Tryptamines
alpha-alkyltryptamines
x-DALT
x-DET
x-DiPT
x-DMT
x-DPT
Ibogaine-related
x-MET
x-MiPT
Others
Others
Dissociatives
(NMDAR
antagonists)
Arylcyclo‐
hexylamines
Ketamine-related
PCP-related
Others
Adamantanes
Diarylethylamines
Morphinans
Others
Deliriants
(mAChR
antagonists)
Others
Cannabinoids
(CB1 agonists)
Natural
Synthetic
AM-x
CPx
HU-x
JWH-x
Misc. designer cannabinoids
D2agonists
GABAA
enhancers
Inhalants
(MixedMOA)
κORagonists
Oneirogens
Others
Retrieved from "https://en.wikipedia.org/w/index.php?title=2C-T-15&oldid=1157148125"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp